$90,000 of GILEAD SCIENCES INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to healthcare, including improving patient access to advanced immunology therapies; Issues related to policies affecting biopharma products pricing, coverage and access in Medicare and Medicaid; Issues related to funding for HIV and HCV screening, linkage to care and treatment; Issues related to breast cancer screening."
You can find more data on corporate lobbying on Quiver Quantitative.
GILD Congressional Stock Trading
Members of Congress have traded $GILD stock 9 times in the past 6 months. Of those trades, 6 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $GILD stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 06/06, 05/05 and 0 sales.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/07 and 1 sale worth up to $15,000 on 05/14.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/31 and 1 sale worth up to $50,000 on 05/12.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 04/16.
- REPRESENTATIVE CAROL D. MILLER purchased up to $15,000 on 03/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GILD Insider Trading Activity
GILD insiders have traded $GILD stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $GILD stock by insiders over the last 6 months:
- ANDREW D DICKINSON (Chief Financial Officer) has made 0 purchases and 10 sales selling 312,785 shares for an estimated $31,619,776.
- JOHANNA MERCIER (Chief Commercial Officer) has made 0 purchases and 5 sales selling 34,000 shares for an estimated $3,674,163.
- DANIEL PATRICK O'DAY (Chairman & CEO) has made 0 purchases and 4 sales selling 20,000 shares for an estimated $2,208,676.
- JEFFREY BLUESTONE sold 5,000 shares for an estimated $548,700
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GILD Hedge Fund Activity
We have seen 912 institutional investors add shares of GILD stock to their portfolio, and 922 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 18,223,410 shares (+45.2%) to their portfolio in Q1 2025, for an estimated $2,041,933,090
- CAPITAL WORLD INVESTORS removed 18,158,461 shares (-25.3%) from their portfolio in Q1 2025, for an estimated $2,034,655,555
- PRICE T ROWE ASSOCIATES INC /MD/ added 11,156,382 shares (+314.6%) to their portfolio in Q1 2025, for an estimated $1,250,072,603
- WELLINGTON MANAGEMENT GROUP LLP removed 8,300,040 shares (-23.3%) from their portfolio in Q1 2025, for an estimated $930,019,482
- JPMORGAN CHASE & CO added 5,470,737 shares (+97.5%) to their portfolio in Q1 2025, for an estimated $612,996,080
- BLACKROCK, INC. removed 4,251,269 shares (-3.5%) from their portfolio in Q1 2025, for an estimated $476,354,691
- MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 3,589,218 shares (-56.9%) from their portfolio in Q1 2025, for an estimated $402,171,876
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GILD Analyst Ratings
Wall Street analysts have issued reports on $GILD in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 05/05/2025
- Oppenheimer issued a "Outperform" rating on 04/25/2025
- Morgan Stanley issued a "Overweight" rating on 04/25/2025
- Cantor Fitzgerald issued a "Overweight" rating on 04/22/2025
- BMO Capital issued a "Outperform" rating on 04/17/2025
- JP Morgan issued a "Overweight" rating on 03/27/2025
- B of A Securities issued a "Buy" rating on 03/05/2025
To track analyst ratings and price targets for GILD, check out Quiver Quantitative's $GILD forecast page.
GILD Price Targets
Multiple analysts have issued price targets for $GILD recently. We have seen 13 analysts offer price targets for $GILD in the last 6 months, with a median target of $120.0.
Here are some recent targets:
- Salim Syed from Mizuho set a target price of $117.0 on 05/05/2025
- Hartaj Singh from Oppenheimer set a target price of $125.0 on 04/25/2025
- Matthew Harrison from Morgan Stanley set a target price of $135.0 on 04/25/2025
- Carter Gould from Cantor Fitzgerald set a target price of $125.0 on 04/22/2025
- Evan Seigerman from BMO Capital set a target price of $120.0 on 04/17/2025
- Chris Schott from JP Morgan set a target price of $130.0 on 03/27/2025
- Mohit Bansal from Wells Fargo set a target price of $140.0 on 03/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
